Smoking cessation medicines like varenicline, bupropion, and nicotine replacement therapy are licensed aids to help individuals quit smoking. E-cigarettes, although not licensed, are also used in some cessation programs, raising safety and efficacy questions.
This review examines their effectiveness and cost-effectiveness, providing insights for policymakers and healthcare providers aiming to reduce smoking-related health burdens.